Cooperative Agreement AID685A1100004

The Department of Public Health Connecticut has been awarded a $478,391 Cooperative Agreement by the National Center for HIV/AIDS, a division of the Centers for Disease Control and Prevention (CDC), under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The purpose of this award is to enable the Connecticut Tuberculosis Control Program (CTBCP) to maintain and improve current tuberculosis (TB) elimination activities in the state. Key objectives include: 1)...

This federal Cooperative Agreement award, provided by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940), supports the Illinois Department of Public Health (IDPH) Tuberculosis Prevention, Control and Elimination Program (IDPHTPCE Program). The $147,801 award, starting on January 1, 2025 and ending on December 31, 2029, funds the IDPHTPCE Program's efforts to conduct...

This is a Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The $219,938 award will support the Hawaii Department of Health's Tuberculosis Control Branch (TBB) in efforts to control and eliminate tuberculosis (TB) in the state of Hawaii from January 1, 2025 to December 31, 2029. Key activities funded through this award include: 1) TB screening, diagnosis, and treatment; 2)...

This federal Cooperative Agreement award from the National Center for HIV/AIDS, a part of the Centers for Disease Control and Prevention (CDC), provides $103,744 in funding to the Indiana Department of Health (IDOH) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The purpose of this award is to assist IDOH in addressing the strategies and implementing the activities identified in their application to support tuberculosis (TB) elimination and laboratory...

The Puerto Rico Department of Health (PRDOH) has been awarded a $21,143 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based grant program (CFDA 93.940). The grant will support PRDOH's efforts to control and eventually eliminate tuberculosis in Puerto Rico, which serves a population of 3.2 million and provides occasional support to the U.S. Virgin Islands. Key activities will include enhancing TB surveillance,...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $273,508 Cooperative Agreement under the HIV Prevention Activities Health Department Based program (CFDA 93.940) to the West Virginia State Health Department. This 5-year award, effective January 1, 2025 through December 31, 2029, will support the West Virginia Tuberculosis (TB) Elimination Program's efforts to eliminate TB in the state. Key activities include: 1) identifying and treating persons with active TB disease; 2)...

The City of New York, through its Department of Health and Mental Hygiene (Health Dept), has been awarded a $537,672 Cooperative Agreement by the National Center for HIV/AIDS to support the Tuberculosis Elimination and Laboratory Cooperative Agreement program (CFDA 93.940). The purpose of this funding is to supplement state and local efforts to prevent, control, and eliminate tuberculosis (TB) as a public health threat in New York City. Key products and services to be delivered under this 5-year...

This $5,023,124 Cooperative Agreement award, funded by the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention under the Global AIDS program (CFDA 93.067), will support the National Tuberculosis Control Program in Cameroon. The 5-year project, running from September 2024 to September 2029, aims to combat HIV/AIDS in Cameroon by strengthening national health systems, expanding access to antiretroviral therapy, improving laboratory capabilities, enhancing...

This $6,082,948 Cooperative Agreement award was granted by the U.S. Centers for Disease Control and Prevention's (CDC) Global AIDS program (CFDA 93.067) to provide technical assistance (TA) to strengthen the national and district-level HIV and TB programming in Lesotho. The primary recipient, (Hisp) Health Information Systems Program South Africa, is a non-profit organization focused on developing and implementing sustainable digital health systems, particularly in the area of health information...

This Federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, provides $1,011,348 to the Texas Biomedical Research Institute to study the impact of HIV on the human alveolar environment and its effects on the early stages of Mycobacterium tuberculosis (M.TB) infection. The research aims to: 1) determine how M.TB exposure to alveolar lining fluid from people living with HIV...